Feline Obesity and Metabolic Dysfunction: From Adipose Inflammation to Insulin Resistance

Why does excess body fat matter beyond a higher number on the weighing scale? In cats, obesity can alter adipose tissue function, inflammatory signalling and glucose, and lipid metabolism. The result is a metabolic environment that can increase the risk of insulin resistance and other complications. 

When Fat Tissue Becomes Metabolically Active 

Adipose tissue is not simply an energy store. In obesity, enlarged adipocytes can become hypoxic and dysfunctional, particularly within visceral abdominal fat. This is associated with increased production of inflammatory mediators such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), alongside reduced adiponectin. Together, these changes contribute to chronic low-grade inflammation^[1]. 

Macrophage infiltration may further amplify inflammatory signalling, although the extent and direct contribution of this process in cats remain incompletely established^[2].

For the clinician, this distinction matters: the metabolic consequences of obesity are not explained by body fat quantity alone. Where fat accumulates and how adipose tissue functions may also influence metabolic risk. 

Lipid Changes Can Signal Metabolic Dysfunction 

Obesity can alter lipid metabolism in cats. Among routine lipid markers, elevated triglycerides appear to be a more reliable indicator of metabolic risk than cholesterol^[3]. 

Excessive fat storage can increase lipolysis, releasing free fatty acids (FFAs) into circulation. The liver can use these FFAs for triglyceride synthesis and very low-density lipoprotein (VLDL) production. Persistent lipid overload may contribute to fat accumulation in tissues such as the liver and skeletal muscle^[4],[5]. 

This creates a potential link between excess adipose tissue, altered lipid handling and impaired insulin action. 

Leptin and Adiponectin: Two Important Signals 

Adipose tissue also influences metabolism through hormones known as adipokines. 

Obese cats have increased circulating leptin concentrations, and leptin resistance has been proposed as a possible feature of feline obesity^[5]. At the same time, adiponectin concentrations decrease with obesity. Reduced adiponectin is associated with impaired insulin sensitivity and altered fatty acid oxidation^[6].

Genetic factors may contribute as well. Polymorphisms in the melanocortin-4 receptor (MC4R) have been associated with body mass index in cats, highlighting a potential genetic component to metabolic regulation^[7]. 

How Obesity Can Affect Insulin Sensitivity 

Cats are particularly susceptible to insulin resistance in the setting of obesity. They also have lower circulating adiponectin concentrations than dogs, which may contribute to this susceptibility^[5]. 

Changes in the expression of genes involved in insulin signalling and lipid metabolism have been identified in obese cats^[5],[8]. Several mechanisms proposed from human and rodent research may also be relevant, including inflammatory cytokine-mediated inhibition of insulin receptor substrate-1 (IRS-1), together with effects from elevated FFAs, tissue hypoxia and mitochondrial dysfunction^[5].

However, these mechanisms should be interpreted carefully. Some of the detailed molecular pathways have been demonstrated mainly in other species, and direct confirmation in cats remains limited. 

A Metabolic Chain Worth Recognising 

The progression can therefore be viewed as a connected process: 

Excess adipose tissue → adipocyte dysfunction → inflammatory and hormonal changes → altered lipid handling → impaired insulin sensitivity 

As obesity progresses, FFAs and lipid intermediates can accumulate in non-adipose tissues. Hepatic and muscular lipid accumulation may contribute to insulin resistance, while lipid toxicity can place additional stress on pancreatic beta cells^[5].

This helps explain why obesity should not be viewed solely as a cosmetic or body-condition issue. 

Clinical Bottom Line 

For an obese cat, body weight and BCS provide the visible starting point, but metabolic health requires a broader perspective. Monitoring trends in body condition alongside relevant metabolic indicators can help identify cats in whom excess adiposity is becoming physiologically consequential. 

The key message is simple: In feline obesity, excess fat can become an active driver of metabolic dysfunction, not merely stored energy.

References:

1. Turner L, Wanasinghe AI, Brunori P, Santosa S. Is adipose tissue inflammation the culprit of obesity‐associated comorbidities?. Obesity Reviews. 2025 Nov;26(11):e13956. https://onlinelibrary.wiley.com/doi/pdf/10.1111/obr.13956
2. Morris DL, Singer K, Lumeng CN. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Current opinion in clinical nutrition and metabolic care. 2011 Jul;14(4):341. https://pmc.ncbi.nlm.nih.gov/articles/PMC4690541/pdf/nihms362221.pdf
3. Okada Y, Ueno H, Mizorogi T, Ohara K, Kawasumi K, Arai T. Diagnostic criteria for obesity disease in cats. Frontiers in veterinary science. 2019 Aug 27;6:284. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2019.00284/pdf
4. Klop B, Elte JW, Castro Cabezas M. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013 Apr 12;5(4):1218-40. https://www.mdpi.com/2072-6643/5/4/1218
5. Wang H, Wang W, Zhang Y, Yao J, Liu Y, Pan L, Wang R, Wang J, Xia Z, Chen L, Xiong W. From pathogenesis to prevention: an update on the management of obesity and its associated comorbidities in cats. Frontiers in Veterinary Science. 2026 Apr 7;13:1797197. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1797197/pdf
6. Baldelli S, Aiello G, Mansilla Di Martino E, Campaci D, Muthanna FM, Lombardo M. The role of adipose tissue and nutrition in the regulation of adiponectin. Nutrients. 2024 Jul 26;16(15):2436. https://www.mdpi.com/2072-6643/16/15/2436
7. Sharma S, Garfield AS, Shah B, Kleyn P, Ichetovkin I, Moeller IH, Mowrey WR, Van der Ploeg LH. Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation. Molecules. 2019 May 16;24(10):1892. https://www.mdpi.com/1420-3049/24/10/1892
8. Yun JE, Kang SR, Kim JY, Kim HJ, Kobayashi M, Arai T. Effect of resveratrol supplementation on lipid metabolism in healthy and obese cats. Frontiers in Veterinary Science. 2025 Apr 16;12:1565367. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2025.1565367/full?utm_source=researchgate.net&utm_medium=article